Production and Characterization of a Human Recombinant Monoclonal Fab Fragment Specific for Influenza A Viruses
Overview
Authors
Affiliations
A human recombinant monoclonal Fab fragment that specifically recognizes all the influenza A virus strains tested was produced in transformed Escherichia coli using the phage display technique. No strain of influenza B virus reacted with it. It was purified after four cycles of panning and by a single passage through an immunoaffinity column. About 1 mg of pure monoclonal antibody was obtained from 1 liter of culture medium in 3 working days. The Fab fragment reacted with a viral 27-kDa protein, which could reasonably be a matrix protein. Indirect immunofluorescence tests performed on virus-infected MDCK cells showed that this Fab fragment was at least equally efficient as other commercial monoclonal antibody-based systems in detecting influenza A viral infections. The potential advantages of human recombinant Fabs on murine monoclonal antibodies are discussed.
Nicasio M, Sautto G, Clementi N, Diotti R, Criscuolo E, Castelli M Viruses. 2012; 4(9):1731-52.
PMID: 23170181 PMC: 3499828. DOI: 10.3390/v4091731.
Clementi N, Mancini N, Solforosi L, Castelli M, Clementi M, Burioni R Int J Mol Sci. 2012; 13(7):8273-8292.
PMID: 22942702 PMC: 3430233. DOI: 10.3390/ijms13078273.
Chandra P, Hazari S, Poat B, Gunduz F, Prabhu R, Liu G Virol J. 2010; 7:118.
PMID: 20529250 PMC: 2903558. DOI: 10.1186/1743-422X-7-118.